Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Gross Profit (2016 - 2025)

INVO Fertility (IVF) has disclosed Gross Profit for 15 consecutive years, with $629345.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit rose 41.53% to $629345.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.7 million, a 3.48% increase, with the full-year FY2024 number at $2.9 million, up 164.63% from a year prior.
  • Gross Profit was $629345.0 for Q3 2025 at INVO Fertility, down from $770051.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $3.0 million in Q4 2021 to a low of $67883.0 in Q2 2022.
  • A 5-year average of $558123.2 and a median of $444686.0 in 2024 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: surged 1510.18% in 2021, then crashed 93.37% in 2022.
  • INVO Fertility's Gross Profit stood at $3.0 million in 2021, then plummeted by 93.37% to $198948.0 in 2022, then surged by 148.81% to $495004.0 in 2023, then surged by 47.18% to $728547.0 in 2024, then decreased by 13.62% to $629345.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Gross Profit are $629345.0 (Q3 2025), $770051.0 (Q2 2025), and $592256.0 (Q1 2025).